Herbas VPB

Print
EN | LT
Supplementary protection
LT - Reumatinių ligų gydymo būdas, naudojant tirpią CTLA4 molekulę
EN - METHODS FOR TREATING RHEUMATIC DISEASES USING A SOLUBLE CTLA4 MOLECULE
SPC
(11) Number of the document C 1372696
(68) Number of the document 1372696
(21) Application number for Supplementary Protection Certificate PA 2008 014
(22) Date of filing the application 2008-11-04
(41) Date of publication of the application 2008-12-29
Date of publication of SPC 2009-05-25
(24) Date of coming into effect of SPC 2021-07-02
Applicant
(71) Bristol-Myers Squibb Company, P.O. Box 4000, Lawrenceville-Princeton Road, Princeton, NJ 08543, US
Grantee
(73) Bristol-Myers Squibb Company, P.O. Box 4000, Lawrenceville-Princeton Road, Princeton, NJ 08543, US
Attorney or representative
(74) Reda ŽABOLIENĖ, METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius, LT
Number, date and code of the country of origin of the first authorization to place the medicinal or plant protection product on the market within regional economic community
(93) EU/1/07/389/001, 2007-05-21, EU/1/07/389/002, 2007-05-21, EU/1/07/389/003, 2007-05-21
Calculated date of expiry of the SPC
(94) 2022-05-23
Name of the product protected by the basic patent
(95) Abataceptum
Paediatric extension
Request filed SPC extension granted until Request refused
2011-09-08 2022-11-23
Last renewal fee
Payment date Validity (years) Amount
2022-07-01 347.00 EUR
Legal status
SPC expired
Last update date 2022-12-09